β-defensin 4 Antibodies

Santa Cruz Biotechnology delivers a wide array of β-defensin 4 monoclonal antibodies for research focused on understanding this important antimicrobial peptide. β-defensin 4 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). β-defensin 4 is a crucial component of the innate immune system, playing a significant role in host defense against microbial infections. β-defensin 4 exhibits antimicrobial activity against a variety of pathogens and modulates inflammatory responses. Understanding β-defensin 4 function is essential for elucidating potential therapeutic applications in infectious diseases and inflammatory conditions. β-defensin 4 expression patterns vary across different tissues and can be influenced by various stimuli, including bacterial and viral infections. Researchers can investigate β-defensin 4's role in maintaining mucosal barrier integrity and its interaction with other immune system components. Current studies explore β-defensin 4's potential as a therapeutic target for developing novel antimicrobial strategies. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of β-defensin 4's role in immune defense and disease treatment.